Stunning Video Is The First To Show CRISPR Editing DNA In Real Time
Stunning Video Is The First To Show CRISPR Editing DNA In Real Time
Single-molecule movie of DNA search and cleavage by CRISPR-Cas9
The video is grainy and dark, but it provides an astonishing first look at CRISPR in action. A team from Kanazawa University and University of Tokyo in Japan used a technique called high-speed atomic-force microscopy to capture the shape of Cas9, the enzyme that actually does the cutting. A tiny needle moves back and forth, rendering details about the enzyme’s shape, moving so quickly that it produces a moving image.
The video took the science world by storm over the weekend, racking up more than 1500 retweets and thousands of likes. CRISPR is definitely a pop star of the science world – and we’ve only begun to scratch the surface of its potential.
[Credits] https://www.gizmodo.com.au/2017/11/stunning-video-is-the-first-to-show-crispr-editing-dna-in-real-time/- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.